Expert Review of Respiratory Medicine

Papers
(The TQCC of Expert Review of Respiratory Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis187
Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2179
False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives84
Pulmonary fibrosis secondary to COVID-19: a narrative review68
Extrapulmonary tuberculosis61
Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis47
Reported quality of life in countries with cases of COVID19: a systematic review41
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential41
Rehabilitation of patients with COVID-1940
Diagnostic approaches in COVID-19: clinical updates39
Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis37
The COVID-19 pandemic: a target for surfactant therapy?34
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management32
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review31
Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management31
Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies30
Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study29
Role of fever and ambient temperature in COVID-1929
COPD patients in a COVID-19 society: depression and anxiety26
Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients26
Ten challenging questions about SARS-CoV-2 and COVID-1924
Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis24
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?23
Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments23
Smoking-associated interstitial lung disease: update and review22
Endo-phenotyping of COPD patients21
Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation19
COVID-19 Smart Diagnosis in the Emergency Department: all-in in Practice19
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies19
The right interface for the right patient in noninvasive ventilation: a systematic review19
Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care18
Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-8518
Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment18
Chronic obstructive pulmonary disease in HIV18
Extra-pulmonary manifestations of COPD and the role of pulmonary rehabilitation: a symptom-centered approach18
Ibuprofen and COVID-19 disease: separating the myths from facts18
Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases17
COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life17
Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India17
The impact of maternal asthma during pregnancy on fetal growth and development: a review17
Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis16
Lung function parameters among Australian Aboriginal ‘apparently healthy’ adults: an Australian Caucasian and Global Lung Function Initiative (GLI-2012) various ethnic norms comparative study16
Machine learning in asthma research: moving toward a more integrated approach16
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials16
Influences of environmental exposures on preterm lung disease16
Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease16
Tuberculosis related stigma in India: roadblocks and the way forward16
Covid-19: a comprehensive review of a formidable foe and the road ahead15
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma15
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients15
Understanding the relationships between environmental factors and exacerbations of COPD15
Innate and adaptive immune responses in respiratory virus infection: implications for the clinic15
Depression and anxiety in patients with interstitial lung disease14
DNA methylation in pulmonary fibrosis and lung cancer14
The rising of allergic respiratory diseases in a changing world: from climate change to migration14
Recent developments in the pathobiology of lung myofibroblasts13
Could E-cigarette vaping contribute to heart disease?13
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer13
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases13
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy13
COPD in Biomass exposed nonsmokers: a different phenotype12
Cognitive impairment in COPD: an often overlooked co-morbidity12
HIV TB coinfection - perspectives from India12
Pediatric bronchoscopy: recent advances and clinical challenges12
Medical thoracoscopy in the diagnosis of pleural disease: a guide for the clinician12
Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease12
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD12
Mediastinal lymphadenopathy: a practical approach12
An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation12
Tuberculosis in children with severe acute malnutrition12
An effective drug against COVID-19: reality or dream?11
Prediction of stroke-associated pneumonia by the A2DS2, AIS-APS, and ISAN scores: a systematic review and meta-analysis11
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy11
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy11
Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China11
SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond11
Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies11
Granulomatous lung disease: clinical aspects10
The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-1910
Association between sarcoidosis and diabetes mellitus: a systematic review and meta-analysis10
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-1910
Comorbidities and mortality risk factors for patients with bronchiectasis10
Myofunctional therapy for OSA: a meta-analysis10
Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population10
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry10
Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-1910
COVID-19 ‘asymptomatic’ patients: an old wives’ tale10
Role of acute exacerbations in skeletal muscle impairment in COPD10
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study10
A comprehensive clinical guide forPneumocystis jiroveciipneumonia: a missing therapeutic target in HIV-uninfected patients9
Bilevel and continuous positive airway pressure and factors linked to all-cause mortality in COVID-19 patients in an intermediate respiratory intensive care unit in Italy9
Management of COVID-19 from the pulmonologist’s perspective: a narrative review9
The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis9
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR9
Effects of anemia on the survival of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis9
Step-up and step-down approaches in the treatment of asthma9
The effect of teach-back training intervention of breathing exercise on the level of dyspnea, six-minutes walking test and FEV1/FVC ratio in patients with chronic obstructive pulmonary disease; a rand9
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment9
Transbronchial Lung Cryobiopsy in children9
Recommendations for COPD management in Central and Eastern Europe8
Cognitive function and life quality of patients with moderate-to-severe obstructive sleep apnea-hypopnea syndrome in China8
Effectiveness, safety and efficacy of INTELLiVENT–adaptive support ventilation, a closed–loop ventilation mode for use in ICU patients – a systematic review8
A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective8
Management of progressive pulmonary fibrosis associated with connective tissue disease8
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK8
Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence8
Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets8
IL-26 in asthma and COPD8
Obstructive sleep apnea: personalizing CPAP alternative therapies to individual physiology8
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons7
Chest radiographs may assist in predicting the outcome in the early phase of Covid-19. UK district general hospital experience of Covid-19 first wave7
Overprescription of short-acting β2-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study7
Influenza and pneumonia-attributed deaths among cancer patients in the United States; a population-based study7
A multimodal approach to detect and monitor early lung disease in cystic fibrosis7
Understanding hydrogen sulfide signaling in neonatal airway disease7
Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis7
The use of tobramycin for Pseudomonas aeruginosa: a review7
High-flow versus conventional nasal cannula oxygen supplementation therapy and risk of hypoxia in gastrointestinal endoscopies: a systematic review and meta-analysis7
Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study7
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy7
Novel therapeutic approaches targeting endotypes of severe airway disease7
Masks in COVID-19: let’s unmask the evidence7
0.037935972213745